Literature DB >> 3880652

Malignant teratoma in the brain. An immunohistochemical study.

Y Nakamura, T Sato, G Nishimura, A Tanimura, Y Takahashi, H Hachisuka, K Masaike, T Yanai, H Hashimoto.   

Abstract

A case of intracranial malignant teratoma found in a 27-year-old man was reported. This unique tumor was found in the right frontal lobe separated from the pineal region and revealed various tissue components such as stratified squamous epithelium, glandular tissues, neuron, glia, ependyma, fibromuscular tissue, cartilage, bone, hemangiomatous lesion, melanin-laden cells, and some germ cell components. An immunohistochemical study demonstrated the presence of S-100 protein, glial fibrillary acidic protein (GFAP), neuron-specific enolase (NSE), carcinoembryonic antigen (CEA), and Factor VIII in some tumourous components. In particular, the distribution of S-100 protein in some germ cells suggested the possibility of the neuroectodermal origin of the germ cells or, alternatively, differentiation to the neuroectoderm.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3880652     DOI: 10.1002/1097-0142(19850101)55:1<103::aid-cncr2820550117>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Combined chemotherapy and radiation therapy for CNS germ cell tumors--the Japanese experience.

Authors:  M Matsutani
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

Review 2.  Metaplastic bone formation in a low grade conus glioma: case report and review of the literature.

Authors:  Vitaly Siomin; Robert Willinsky; Patrick Shannon; Abhijit Guha
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

3.  A malignant mixed germ cell tumor originating from the pituitary gland with a suprasellar extension: a case report.

Authors:  S K Lim; H C Chung; W T Kim; K B Huh; S S Chung; D I Kim; H J Chung
Journal:  Korean J Intern Med       Date:  1986-07       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.